KRAS G12S MUTATION

Clinical trials for KRAS G12S MUTATION explained in plain language.

Never miss a new study

Get alerted when new KRAS G12S MUTATION trials appear

Sign up with your email to follow new studies for KRAS G12S MUTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New drug targets tough cancers in early trial

Disease control Recruiting now

This early-phase study tests a new drug called KQB365 in adults with advanced solid tumors (like colorectal cancer) that have specific KRAS mutations (G12C or G12S). The main goals are to find a safe dose and see if the drug can shrink tumors when given alone or with other cancer…

Matched conditions: KRAS G12S MUTATION

Phase: PHASE1 • Sponsor: Kumquat Biosciences Inc. • Aim: Disease control

Last updated May 15, 2026 11:57 UTC

KRAS G12S MUTATION

Get alerted when new KRAS G12S MUTATION trials appear

New drug targets tough cancers in early trial